These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9636518)

  • 1. Decreasing pancreatic toxicity of tacrolimus by dosage reduction.
    Uchida K; Tominaga Y; Haba T; Katayama A; Ichimori T; Yamada K; Hibi Y; Uemura O; Morozumi K; Takagi H
    Transplant Proc; 1998 Jun; 30(4):1276-8. PubMed ID: 9636518
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of tacrolimus: clinically relevant aspects.
    Undre NA; Stevenson P; Schäfer A
    Transplant Proc; 1999 Nov; 31(7A):21S-24S. PubMed ID: 10576037
    [No Abstract]   [Full Text] [Related]  

  • 3. Three-times-daily monotherapy with tacrolimus (FK 506) in kidney transplantation.
    Ichikawa Y; Hanafusa T; Kyo M; Fukunishi T; Nagano S
    Int J Urol; 1996 May; 3(3):180-3. PubMed ID: 8776613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes in renal transplant recipients treated with tacrolimus.
    Akioka K; Okamoto M; Nakamura K; Ushigome H; Kadotani Y; Ohmori Y; Yoshimura N
    Transplant Proc; 2002 Aug; 34(5):1774-5. PubMed ID: 12176570
    [No Abstract]   [Full Text] [Related]  

  • 5. Study of pharmacokinetic parameters of tacrolimus by different oral administration periods in renal transplantation.
    Saito K; Suwa M; Nakagawa Y; Utsugi R; Tanikawa T; Tomita Y; Takahashi K
    Transplant Proc; 2002 Aug; 34(5):1726-9. PubMed ID: 12176553
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary tacrolimus-based immunosuppression in renal allograft recipients: a single center experience.
    Lye WC
    Transplant Proc; 2000 Nov; 32(7):1700-1. PubMed ID: 11119898
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation.
    Kokado Y; Takahara S; Kyo M; Ichimaru N; Toki K; Wang JD; Okuyama A
    Transplant Proc; 1999; 31(1-2):1151-4. PubMed ID: 10083515
    [No Abstract]   [Full Text] [Related]  

  • 8. Malabsorption of tacrolimus in kidney transplant recipients: a Japanese single center experience.
    Tanabe K; Tokumoto T; Ishikawa N; Shimizu T; Okuda H; Ito S; Shinmura H; Inui M; Harano M; Manu M; Koga S; Shiroyanagi Y; Goya N; Yagisawa T; Fuchinoue S; Toma H
    Transplant Proc; 2000 Nov; 32(7):1718-20. PubMed ID: 11119906
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of FK 506 and mycophenolic acid after the administration of a FK 506-based regimen in combination with mycophenolate mofetil in kidney transplantation.
    Undre NA; van Hooff J; Christiaans M; Vanrenterghem Y; Donck J; Heeman U; Kohnle M; Zanker B; Land W; Morales JM; Andrés A; Schäfer A; Stevenson P
    Transplant Proc; 1998 Jun; 30(4):1299-302. PubMed ID: 9636527
    [No Abstract]   [Full Text] [Related]  

  • 10. New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression.
    Wagner K; Webber SA; Kurland G; Boyle GJ; Miller SA; Cipriani L; Griffith BP; Fricker FJ
    J Heart Lung Transplant; 1997 Mar; 16(3):275-82. PubMed ID: 9087870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of breakfast on the oral bioavailability of tacrolimus and changes in pharmacokinetics at different times posttransplant in renal transplant recipients.
    Christiaans M; van Duijnhoven E; Beysens T; Undre N; Schäfer A; van Hooff J
    Transplant Proc; 1998 Jun; 30(4):1271-3. PubMed ID: 9636516
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial.
    Pascual J; del Castillo D; Cabello M; Pallardó L; Grinyó JM; Fernández AM; Brunet M
    Transplantation; 2010 Apr; 89(8):994-1000. PubMed ID: 20335831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of tacrolimus dosing on glucose metabolism in an experimental rat model.
    Malinowski M; Pratschke J; Lock J; Neuhaus P; Stockmann M
    Ann Transplant; 2010; 15(3):60-5. PubMed ID: 20877268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental study of tacrolimus immunosuppression on the mode of administration: efficacy of constant intravenous infusion avoiding C(max).
    Ishibashi M; Yoshida K; Ozono S; Hirao Y; Takahashi K; Kawamura Y; Ohara K
    Transplant Proc; 2001; 33(1-2):559-60. PubMed ID: 11266958
    [No Abstract]   [Full Text] [Related]  

  • 15. An update on the safety of tacrolimus in kidney transplant recipients, with a focus on tacrolimus minimization.
    Jouve T; Noble J; Rostaing L; Malvezzi P
    Expert Opin Drug Saf; 2019 Apr; 18(4):285-294. PubMed ID: 30909754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus and new onset diabetes mellitus: the effect of steroid weaning.
    Baran DA; Ashkar J; Galin ID; Sandler D; Segura L; Courtney MC; Correa R; Chan M; Lansman SL; Spielvogel D; Cheng J; Gass AL
    Transplant Proc; 2002 Aug; 34(5):1711-2. PubMed ID: 12176547
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients.
    Lumlertgul D; Noppakun K; Rojanasthien N; Kanchanarattanakorn K; Jittikanont S; Manoyot A; Bunnachak D; Ophascharoensuk V
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S73-8. PubMed ID: 17044457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus after renal transplantation under FK 506 (tacrolimus) as primary immunosuppression.
    Tanabe K; Koga S; Takahashi K; Sonda K; Tokumoto T; Babazono T; Yagisawa T; Toma H; Kawai T; Fuchinoue S; Teraoka S; Ota K
    Transplant Proc; 1996 Jun; 28(3):1304-5. PubMed ID: 8658670
    [No Abstract]   [Full Text] [Related]  

  • 19. Tacrolimus nephrotoxicity after renal transplantation.
    Katari SR; Magnone M; Shapiro R; Jordan M; Scantlebury V; Vivas C; Gritsch HA; McCauley J; Starzl T; Demetris AJ; Randhawa PS
    Transplant Proc; 1997; 29(1-2):311. PubMed ID: 9123014
    [No Abstract]   [Full Text] [Related]  

  • 20. Two cases of tacrolimus-induced alopecia following kidney transplantation.
    Ushigome H; Yoshimura N; Okamoto M; Najima H; Hamajima T; Nakai I; Oka T
    Transplant Proc; 1999 Nov; 31(7):2885-6. PubMed ID: 10578326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.